| Line item | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|
| Revenue | $2.87T | $2.81T | $2.67T | $2.52T | $2.29T |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $646.05B | $627.63B | $559.41B | $522.78B | $456.80B |
| Operating Income | $331.83B | $360.71B | $313.99B | $302.08B | $258.81B |
| Interest Expense | $169.05B | $188.33B | $127.62B | $68.23B | $78.07B |
| Tax Expense | $128.83B | $131.39B | $87.50B | $187.26B | $90.75B |
| Net Income | $351.63B | $346.13B | $273.07B | $312.13B | $192.38B |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | $1.14B | $1.16B | $1.18B | $1.20B | $1.24B |